Derek Carbaugh, PhD
About Derek Carbaugh, PhD
Derek Carbaugh, PhD, is a Scientist II at Asklepios BioPharmaceutical, Inc. He has a background in Biomedical Sciences and Molecular Biology, with experience in both academic and industry research.
Current Role at Asklepios BioPharmaceutical
Derek Carbaugh currently holds the position of Scientist II at Asklepios BioPharmaceutical, Inc. (AskBio), a role he has occupied since 2022. In this capacity, he contributes to the company's research and development efforts, focusing on advancements in gene therapy and related biopharmaceutical technologies. His work is integral to the ongoing projects at AskBio, which is known for its innovative approaches to addressing genetic disorders.
Previous Experience at Asklepios BioPharmaceutical
Prior to his current role, Derek served as Scientist I at Asklepios BioPharmaceutical from 2020 to 2022. During this time, he was involved in various research initiatives aimed at enhancing the understanding and application of adeno-associated virus (AAV) technologies. His contributions during this period laid the groundwork for his current responsibilities and furthered the company's mission in gene therapy.
Education and Expertise in Biomedical Sciences
Derek Carbaugh earned his Doctor of Philosophy (Ph.D.) in Biomedical Sciences from the University of North Carolina at Chapel Hill, completing his studies from 2015 to 2020. His doctoral research focused on significant aspects of gene therapy, equipping him with a robust foundation in the field. Additionally, he holds a Bachelor's degree in Molecular Biology from Millersville University of Pennsylvania, which he obtained from 2011 to 2014.
Research Experience at University of North Carolina at Chapel Hill
Derek's research experience includes a five-year tenure as a Doctoral Student at the University of North Carolina at Chapel Hill, where he conducted extensive research in the field of genetics. He also completed a two-month internship as a Genetics Research Intern at the same institution in 2014. This combination of academic and practical experience has contributed to his expertise in molecular biology and gene therapy.
Presentations and Contributions to Scientific Community
Derek presented his research on the development of a Split Rep/Cap System to improve AAV capsid production at the ASGCT 2021 Virtual Meeting. This presentation highlights his active engagement in the scientific community and his contributions to advancing knowledge in gene therapy technologies.